Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Glycemic Control in T2D Patients Initiating Insulin

Diabetes Obes Metab; ePub 2017 Apr 10; Mauricio, et al

Starting patients on insulin with or without oral anti-hyperglycemic medication is linked to suboptimal glycemic control in the short- and long-term, according to an observational, retrospective longitudinal analysis involving more than 40,000 individuals.

Participants were insulin-naïve, aged ≥30 years, and had type 2 diabetes. Investigators looked at the factors occurring 0 to 3 months after initiating insulin that correlated with glycemic control after that time. Among the results:

  • 2 in every 10 patients achieved HbA1c of ≤7% at 3 months; more than one-fourth achieved such at 2 years.
  • Those who failed to reach the target HbA1c at 3 months were nearly 4 times more likely to miss the target at 2 years.
  • Nearly 1 in every 10 patients experienced a recorded hypoglycemic event over 2 years.
  • Patients who experienced hypoglycemia within the first 3 months were nearly 6 times more likely to have such an event later.

Citation:

Mauricio D, Meneghini L, Seufert J, et al. Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA. [Published online ahead of print April 10, 2017]. Diabetes Obes Metab. doi:10.1111/dom.12927.